利润表（Omega Healthcare Investors Inc）
| 2024年三季报 | 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 起始日期 | 2024-01-01 | 2024-01-01 | 2024-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 营业收入(元) | 772,072,000.00 | 496,044,000.00 | 243,299,000.00 | 949,740,000.00 | 710,421,000.00 | 468,389,000.00 | 218,202,000.00 | 878,244,000.00 | 733,394,000.00 | 493,964,000.00 | 249,315,000.00 |
| 投资收益(元) | - | - | - | - | - | - | - | - | 36,481,000.00 | 22,371,000.00 | 10,594,000.00 |
| 其他收入(元) | 772,072,000.00 | 496,044,000.00 | 243,299,000.00 | 949,740,000.00 | 710,421,000.00 | 468,389,000.00 | 218,202,000.00 | 878,244,000.00 | 696,913,000.00 | 471,593,000.00 | 238,721,000.00 |
| 营业支出(元) | 487,218,000.00 | 323,960,000.00 | 174,072,000.00 | 793,580,000.00 | 595,711,000.00 | 401,212,000.00 | 199,831,000.00 | 799,668,000.00 | 519,566,000.00 | 341,896,000.00 | 167,733,000.00 |
| 收购及保险费用(元) | 10,820,000.00 | 4,383,000.00 | 2,603,000.00 | 5,341,000.00 | 1,183,000.00 | 1,062,000.00 | 639,000.00 | 42,006,000.00 | - | - | - |
| 一般及行政费用(元) | 65,438,000.00 | 43,680,000.00 | 21,532,000.00 | 81,504,000.00 | 62,971,000.00 | 42,684,000.00 | 20,526,000.00 | 69,397,000.00 | 53,402,000.00 | 35,160,000.00 | 16,385,000.00 |
| 折旧和摊销(元) | 226,036,000.00 | 148,791,000.00 | 74,557,000.00 | 319,682,000.00 | 244,008,000.00 | 163,210,000.00 | 81,192,000.00 | 332,407,000.00 | 248,668,000.00 | 165,959,000.00 | 82,752,000.00 |
| 其他经营支出(元) | 184,924,000.00 | 127,106,000.00 | 75,380,000.00 | 387,053,000.00 | 287,549,000.00 | 194,256,000.00 | 97,474,000.00 | 355,858,000.00 | 217,496,000.00 | 140,777,000.00 | 68,596,000.00 |
| 营业利润(元) | 284,854,000.00 | 172,084,000.00 | 69,227,000.00 | 156,160,000.00 | 114,710,000.00 | 67,177,000.00 | 18,371,000.00 | 78,576,000.00 | 213,828,000.00 | 152,068,000.00 | 81,582,000.00 |
| 加：税前利润其他项目(元) | 17,244,000.00 | 18,663,000.00 | 2,700,000.00 | 98,891,000.00 | 79,656,000.00 | 31,523,000.00 | 17,182,000.00 | 364,826,000.00 | 181,842,000.00 | 137,347,000.00 | 114,799,000.00 |
| 持续经营税前利润(元) | 302,098,000.00 | 190,747,000.00 | 71,927,000.00 | 255,051,000.00 | 194,366,000.00 | 98,700,000.00 | 35,553,000.00 | 443,402,000.00 | 395,670,000.00 | 289,415,000.00 | 196,381,000.00 |
| 减：所得税(元) | 7,877,000.00 | 4,561,000.00 | 2,581,000.00 | 6,255,000.00 | 2,092,000.00 | 334,000.00 | -1,292,000.00 | 4,561,000.00 | 3,535,000.00 | 2,344,000.00 | 1,225,000.00 |
| 持续经营净利润(元) | 294,221,000.00 | 186,186,000.00 | 69,346,000.00 | 248,796,000.00 | 192,274,000.00 | 98,366,000.00 | 36,845,000.00 | 438,841,000.00 | 392,135,000.00 | 287,071,000.00 | 195,156,000.00 |
| 税后利润其他项目(元) | 7,118,000.00 | 239,000.00 | - | - | - | - | - | - | - | - | - |
| 净利润(元) | 301,339,000.00 | 186,425,000.00 | 69,346,000.00 | 248,796,000.00 | 192,274,000.00 | 98,366,000.00 | 36,845,000.00 | 438,841,000.00 | 392,135,000.00 | 287,071,000.00 | 195,156,000.00 |
| 减：少数股东损益(元) | 8,354,000.00 | 5,202,000.00 | 1,985,000.00 | 6,616,000.00 | 5,095,000.00 | 2,568,000.00 | 903,000.00 | 11,914,000.00 | 10,787,000.00 | 7,997,000.00 | 5,549,000.00 |
| 归属于母公司股东净利润(元) | 292,985,000.00 | 181,223,000.00 | 67,361,000.00 | 242,180,000.00 | 187,179,000.00 | 95,798,000.00 | 35,942,000.00 | 426,927,000.00 | 381,348,000.00 | 279,074,000.00 | 189,607,000.00 |
| 归属于普通股股东净利润(元) | 292,985,000.00 | 181,223,000.00 | 67,361,000.00 | 242,180,000.00 | 187,179,000.00 | 95,798,000.00 | 35,942,000.00 | 426,927,000.00 | 381,348,000.00 | 279,074,000.00 | 189,607,000.00 |
| 每股股息 | |||||||||||
| 每股收益 | |||||||||||
| 基本每股收益－普通股(元) | 1.16 | 0.73 | 0.27 | 1.01 | 0.78 | 0.41 | 0.15 | 1.81 | 1.61 | 1.17 | 0.79 |
| 摊薄每股收益－普通股(元) | 1.14 | 0.72 | 0.27 | 1.00 | 0.78 | 0.40 | 0.15 | 1.80 | 1.60 | 1.17 | 0.79 |
| 其他全面收益(元) | 34,388,000.00 | 5,158,000.00 | 2,589,000.00 | 9,286,000.00 | 8,056,000.00 | 21,649,000.00 | 1,243,000.00 | 23,179,000.00 | 8,692,000.00 | 5,872,000.00 | 8,769,000.00 |
| 全面收益总额(元) | 335,727,000.00 | 191,583,000.00 | 71,935,000.00 | 258,082,000.00 | 200,330,000.00 | 120,015,000.00 | 38,088,000.00 | 462,020,000.00 | 400,827,000.00 | 292,943,000.00 | 203,925,000.00 |
| 本公司拥有人应占全面收益总额(元) | 326,385,000.00 | 186,230,000.00 | 69,875,000.00 | 251,193,000.00 | 194,997,000.00 | 116,826,000.00 | 37,150,000.00 | 449,452,000.00 | - | 284,775,000.00 | - |
| 非控股权益应占全面收益总额(元) | 9,342,000.00 | 5,353,000.00 | 2,060,000.00 | 6,889,000.00 | 5,333,000.00 | 3,189,000.00 | 938,000.00 | 12,568,000.00 | 400,827,000.00 | 8,168,000.00 | 203,925,000.00 |
| 公告日期 | 2024-10-31 | 2024-08-02 | 2024-05-03 | 2024-02-12 | 2023-11-03 | 2023-08-03 | 2023-05-03 | 2023-02-14 | 2022-11-03 | 2022-08-02 | 2022-05-03 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||||||
| 核数师 |